Ligand Pharmaceuticals (LGND) Stock Chart & Stock Price History $113.66 +1.10 (+0.98%) Closing price 04:00 PM EasternExtended Trading$113.42 -0.23 (-0.21%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Ligand Pharmaceuticals Stock Price Performance The Ligand Pharmaceuticals (LGND) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 34.05%, with a year-to-date return of 6.08%. In the past month, the stock has increased 11.83%, reflecting recent market activity. As of the latest close, Ligand Pharmaceuticals traded at $112.56 with a market cap of $2.17 billion and volume of 109,742 shares. Five years ago, the stock traded at $111.91, representing a 1.56% increase over that period. At the time, it had a market cap of $1.80 billion and a volume of 352,700 shares. Receive LGND Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ligand Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.43%1 Month Performance+11.83%3 Month Performance+4.53%Year-To-Date Performance+6.08%1 Year Performance+34.05%5 Year Performance+1.56% LGND Stock Chart for Wednesday, July, 2, 2025 LGND Chart by TradingView Ligand Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/02/2025$112.56$113.66+0.98%$114.68$111.72106,499 shs$2.19 billion07/01/2025$113.68$112.56-0.99%$115.53$112.11109,742 shs$2.17 billion06/30/2025$114.15$113.68-0.41%$115.38$113.27111,377 shs$2.19 billion06/27/2025$115.69$114.15-1.33%$116.18$112.77327,870 shs$2.20 billion06/26/2025$115.72$115.69-0.03%$116.61$113.33159,425 shs$2.23 billion06/25/2025$118.22$115.72-2.11%$118.25$115.66146,554 shs$2.23 billion06/24/2025$114.97$118.22+2.83%$118.58$114.18135,249 shs$2.28 billion06/23/2025$114.07$114.97+0.79%$115.10$110.00115,184 shs$2.22 billion06/20/2025$114.64$114.07-0.50%$114.94$112.42259,225 shs$2.20 billion06/19/2025$114.64$114.64$115.54$112.00144,654 shs$2.21 billion Get the Latest News and Ratings for LGND and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ligand Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/18/2025$112.54$114.64+1.87%$115.54$112.00144,654 shs$2.21 billion06/17/2025$115.01$112.54-2.15%$116.16$111.88123,652 shs$2.17 billion06/16/2025$112.50$115.01+2.23%$115.26$112.0596,488 shs$2.22 billion06/13/2025$114.45$112.50-1.70%$113.72$110.1883,330 shs$2.17 billion06/12/2025$115.39$114.45-0.81%$115.89$113.60121,715 shs$2.21 billion06/11/2025$113.42$115.39+1.74%$116.40$112.67183,799 shs$2.23 billion06/10/2025$109.48$113.42+3.60%$114.95$106.30166,245 shs$2.19 billion06/09/2025$105.99$109.48+3.29%$109.77$103.43121,916 shs$2.11 billion06/06/2025$104.18$105.99+1.74%$106.70$103.6891,810 shs$2.04 billion06/05/2025$103.80$104.18+0.37%$104.38$102.5081,774 shs$2.01 billion06/04/2025$102.35$103.80+1.42%$103.98$101.67129,295 shs$2.00 billion06/03/2025$101.64$102.35+0.70%$102.95$101.3083,248 shs$1.97 billion06/02/2025$103.17$101.64-1.48%$103.79$100.6799,876 shs$1.96 billion Related Companies RGEN Stock Chart HALO Stock Chart MDGL Stock Chart IONS Stock Chart ALKS Stock Chart BCRX Stock Chart FOLD Stock Chart CLDX Stock Chart INVA Stock Chart DVAX Stock Chart Receive LGND Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ligand Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LGND) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Pentagon just made a National Security move...This "awesome resource" could power America for 30,000 years... We sent one of our smartest researchers.......Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ligand Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Ligand Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LGND Stock Alerts